Nanodrug Modified with Engineered Cell Membrane Targets CDKs to Activate Apd-L1 Immunotherapy Against Liver Metastasis of Immune-Desert Colon Cancer.
JOURNAL OF CONTROLLED RELEASE（2024）
关键词
Engineered cell membrane,Nanodrug,CDKs,Microsatellite stable,colon cancer liver metastasis,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要